AT505500A3 - Verwendung von 2-hydroxy-1-(4-sulfo-1- naphthylazo)naphthalen-6,8-disulfonsäure in der medizin - Google Patents

Verwendung von 2-hydroxy-1-(4-sulfo-1- naphthylazo)naphthalen-6,8-disulfonsäure in der medizin Download PDF

Info

Publication number
AT505500A3
AT505500A3 AT0098608A AT9862008A AT505500A3 AT 505500 A3 AT505500 A3 AT 505500A3 AT 0098608 A AT0098608 A AT 0098608A AT 9862008 A AT9862008 A AT 9862008A AT 505500 A3 AT505500 A3 AT 505500A3
Authority
AT
Austria
Prior art keywords
naphthylazo
sulfo
naphthalene
hydroxy
medicine
Prior art date
Application number
AT0098608A
Other languages
English (en)
Other versions
AT505500B1 (de
AT505500A2 (de
Inventor
Christian Pichler
Original Assignee
Christian Pichler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian Pichler filed Critical Christian Pichler
Priority to AT0098608A priority Critical patent/AT505500B1/de
Publication of AT505500A2 publication Critical patent/AT505500A2/de
Publication of AT505500A3 publication Critical patent/AT505500A3/de
Application granted granted Critical
Publication of AT505500B1 publication Critical patent/AT505500B1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0098608A 2007-06-21 2008-06-19 2-hydroxy-1-(4-sulfo-1-naphthylazo)naphthalen- 6,8-disulfonsäure in der zur verwendung in der medizin AT505500B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0098608A AT505500B1 (de) 2007-06-21 2008-06-19 2-hydroxy-1-(4-sulfo-1-naphthylazo)naphthalen- 6,8-disulfonsäure in der zur verwendung in der medizin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0096707A AT505147B1 (de) 2007-06-21 2007-06-21 Verwendung von 2-hydroxy-1-(4-sulfo-1-naphthylazo)naphthalen-6 8-disulfonsäure zur herstellung eines arzneimittels zur therapie der rhinitis allergica
AT0098608A AT505500B1 (de) 2007-06-21 2008-06-19 2-hydroxy-1-(4-sulfo-1-naphthylazo)naphthalen- 6,8-disulfonsäure in der zur verwendung in der medizin

Publications (3)

Publication Number Publication Date
AT505500A2 AT505500A2 (de) 2009-01-15
AT505500A3 true AT505500A3 (de) 2010-10-15
AT505500B1 AT505500B1 (de) 2011-03-15

Family

ID=39944541

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0096707A AT505147B1 (de) 2007-06-21 2007-06-21 Verwendung von 2-hydroxy-1-(4-sulfo-1-naphthylazo)naphthalen-6 8-disulfonsäure zur herstellung eines arzneimittels zur therapie der rhinitis allergica
AT0098608A AT505500B1 (de) 2007-06-21 2008-06-19 2-hydroxy-1-(4-sulfo-1-naphthylazo)naphthalen- 6,8-disulfonsäure in der zur verwendung in der medizin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0096707A AT505147B1 (de) 2007-06-21 2007-06-21 Verwendung von 2-hydroxy-1-(4-sulfo-1-naphthylazo)naphthalen-6 8-disulfonsäure zur herstellung eines arzneimittels zur therapie der rhinitis allergica

Country Status (1)

Country Link
AT (2) AT505147B1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010055371A1 (de) * 2008-11-13 2010-05-20 Christian Pichler Medikament zur inhibition der synthese der leukotriene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191414000A (en) * 1914-06-10 1915-01-21 Isabella Georgeson A Preparation for Medicinal Purposes.
TWI314454B (en) * 2005-01-04 2009-09-11 Ct Lab Inc An oral liquid pharmaceutical composition of leukotriene antagonists

Also Published As

Publication number Publication date
AT505147A4 (de) 2008-11-15
AT505500B1 (de) 2011-03-15
AT505147B1 (de) 2008-11-15
AT505500A2 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
EP2060040A4 (de) Verwendung von satztokens in transaktionen
HUE038279T2 (hu) Klotho-béta-agonista antitest cukorbetegség vagy inzulinrezisztencia kezelésében történõ alkalmazásra
DE112007000789A5 (de) Verwendung von Bora-tetraazepentalenen
HRP20160859T1 (hr) Modificirani proteini rsv f i postupci njihove upotrebe
BRPI0906549A2 (pt) Bandagens médicas com válvulas e kits contendo as mesmas.
FI20075090L (fi) Menetelmä kauran fraktioimiseksi, näin saadut tuotteet ja käyttö
DK2338116T3 (da) Dokumentbaserede arbejdsgange
BRPI0812221A2 (pt) Ácidos benzoilamino-indan-2-carboxílicos substituídos e compostos relacionados.
EP2791159A4 (de) Modifizierte nucleinsäuren und akutbehandlungsverwendungen davon
EP2760879C0 (de) Proteinhaltige haftstoffe, ihre herstellung und verwendung
EP2268813A4 (de) Rna-moleküle und ihre verwendung
DK2252633T3 (da) Anti-TrkA antistoffer og derivater deraf
DE602005022859D1 (de) Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK2334307T3 (da) Flerlaget blodprodukt
PL2140269T3 (pl) Podpis białkowy/znaczniki do wykrywania gruczolakoraka
ATE477798T1 (de) Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung
EP3866450C0 (de) Kontextverlinkungen zur verwaltung von persönlichen informationen
BR112014008224A2 (pt) derivados do fator vii e viia de coagulação sanguínea, conjugados e complexos que incluem o mesmo e utilização do mesmo
BRPI0923796A2 (pt) compostos antivirais, tratamento e ensaio
ATE401891T1 (de) Verwendung von meloxicam-formulierungen in der veterinärmedizin
CY1117674T1 (el) Χρηση παραγωγων των orvinol και thevinol ως θεραπευτικη αγωγη στην καταχρηση αλκοολ και φαρμακων
EP2141073A4 (de) Elektronenstrahlsterilisator
BRPI0907486A2 (pt) Triazolpiridazinas como inibidores de par1, sua produção e uso como medicamentos
DE602006008834D1 (de) Binäre hyaluronsäure-gemische und ihre therapeutische verwendung

Legal Events

Date Code Title Description
MM01 Lapse because of not paying annual fees

Effective date: 20130619